As part of a full franchise strategy review, a leading pharmaceutical company was looking to evaluate its global portfolio of existing partnerships with Digital Health ventures to confirm fitness for purpose
Working closely with the client’s franchise and BD teams, Galen Growth ran an analysis of the client’s existing global portfolio of ventures to assess the operational maturity of each. Over 70 ventures were assessed for their clinical, commercial and operational fitness to enable a fresh prioritisation
| Number of countries | Global |
| Number of Key TAs analysed | 1 |
| Number of ventures screened | 70+ |
| Number of ventures shortlisted | N/A |
Contact us to explore how your organisation can fast track its Digital Health strategy with Galen Growth
